Insmed
INSM
101.74
-3.49
-3.32%
Insmed
US · INSM
#794 by market cap
Listed 1970
101.74
-3.49
-3.32%
Live - 5344 symbols - heartbeat 135s ago
· 2026-10-08 08:58
Pre-market
101.02
-0.71%
After-hours
103.00
+1.23%
Overnight
101.99
+0.25%
- Market cap
- 22.22B
- P/E (TTM)i
- -24.69
- P/Bi
- 29.33
- EPSi
- -6.42
- Div yieldi
- 0.00%
- 52W posi
- 9%
Reader sentiment
Are you bullish or bearish on INSM?
Anonymous reader poll. Unscientific, not investment advice.
About Insmed
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
- Founded
- 1988
- CEO
- Mr. William H. Lewis, J.D.,M.B.A.
- Employees
- 1,664
- Headquarters
- Bridgewater, New Jersey, United States of America
- Fiscal year end
- 12-31
- Website
- insmed.com
Company profile
- Exchange
- US
- Symbol
- INSM
- Market-cap rank
- #794
- Listing date
- 1970-01-01
- Market cap
- 22.22B
- Float cap
- 22.07B
- Shares out
- 218.38M
- Float shares
- 216.93M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-10-08 08:58:30 · For reference only, not investment advice and not tailored to your situation.